About Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
During the past decade, Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on
average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik" are
"Non-Hodgkin's Lymphoma" (3 trials), "B-cell Lymphoma" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
Most popular intervention types in "Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (4 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials) and "Vincristine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
The vast majority of trials in "Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik" are
6 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
Currently, there are NaN active trials in "Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".